{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:22:38Z","timestamp":1783570958240,"version":"3.55.0"},"publisher-location":"Chichester, UK","reference-count":137,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003263.pub4","type":"reference-entry","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T14:55:39Z","timestamp":1263826539000},"source":"Crossref","is-referenced-by-count":35,"title":["Interventions for vitiligo"],"prefix":"10.1002","author":[{"given":"Maxine E","family":"Whitton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Pinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Lushey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Leonardi-Bee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urb\u00e0","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"10.1002\/14651858.CD003263.pub4-BIB1|cit1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2133.2005.06556.x","article-title":"A randomised placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo","volume":"153","author":"Agarwal","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB2|cit2","first-page":"48","article-title":"A comparison between systemic PUVA therapy alone and combined with topical calcipotriol in the treatment of generalized vitiligo","volume":"8","author":"Akhyani","year":"2005","journal-title":"Iranian Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB3|cit3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0781.2008.00385.x","article-title":"Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: A left-right comparative study","volume":"24","author":"Anbar","year":"2008","journal-title":"Photodermatology, Photoimmunology and Photomedicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB4|cit4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1346-8138.2006.00079.x","article-title":"Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo","volume":"33","author":"Arca","year":"2006","journal-title":"Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB5|cit5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2340\/00015555-0469","article-title":"Targeted broadband ultraviolet B phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: A randomised, double-blind study","volume":"88","author":"Asawanonda","year":"2008","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB6|cit6","first-page":"49","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman","year":"2004","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003263.pub4-BIB7|cit7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: An open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB8|cit8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo - A multi-centre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD003263.pub4-BIB9|cit9","first-page":"683","article-title":"Comparative study of two psoralens in topical phototherapy for vitiligo","volume":"76","author":"Cestari","year":"2001","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1002\/14651858.CD003263.pub4-BIB10|cit10","first-page":"1400","article-title":"Comparison of melanocytes transplantation methods for the treatment of vitiligo","volume":"30","author":"Czajkowski","year":"2004","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003263.pub4-BIB11|cit11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1610-0387.2006.06124.x","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid","year":"2006","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft Journal of the German Society of Dermatology: JDDG"},{"key":"10.1002\/14651858.CD003263.pub4-BIB12|cit12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","article-title":"Antioxidants and narrow band UVB in the treatment of vitiligo: A double-blind, placebo-controlled trial","volume":"32","author":"Dell'Anna","year":"2007","journal-title":"Clinical and Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB13|cit13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0781.2006.00229.x","article-title":"Ultraviolet A in vitiligo","volume":"22","author":"El-Mofty","year":"2006","journal-title":"Photodermatology Photoimmunology Photomedicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB14|cit14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2133.2001.04286.x","article-title":"Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study","volume":"145","author":"Ermis","year":"2001","journal-title":"The British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB15|cit15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: A double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD003263.pub4-BIB16|cit16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1967.tb11461.x","article-title":"The treatment of vitiligo with psoralens and triamcinolone by mouth","volume":"79","author":"Farah","year":"1967","journal-title":"The British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB17|cit17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB18|cit18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modelling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB19|cit19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2133.2004.06321.x","article-title":"Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients","volume":"152","author":"Hofer","year":"2005","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB20|cit20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1974.tb13086.x","article-title":"Treatment of vitiligo with 0.1% betamethasone 17-valerate in isopropyl alcohol - A double-blind trial","volume":"91","author":"Kandil","year":"1974","journal-title":"The British Journal of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD003263.pub4-BIB21|cit21","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: A pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatologic Surgery: official publication for the American Society of Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB22|cit22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-4362.1995.tb01570.x","article-title":"Comparison of 0.05% clobetasol propionate cream and topical PUVAsol in childhood vitiligo","volume":"14","author":"Khalid","year":"1995","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB23|cit23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00042728-200504000-00010","article-title":"Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo","volume":"31","author":"Khandpur","year":"2005","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003263.pub4-BIB24|cit24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their contribution in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB25|cit25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2230.2005.02037.x","article-title":"Tacalcitol and narrow-band phototherapy in patients with vitiligo","volume":"31","author":"Leone","year":"2006","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB26|cit26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomised trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB27|cit27","first-page":"17","article-title":"Comparison between narrow-band UVB with topical corticosteroid and narrow-band UVB with placebo in the treatment of vitiligo: A randomized controlled trial","volume":"14","author":"Lim-Ong","year":"2005","journal-title":"Journal of the Phillipine Dermatological Society"},{"key":"10.1002\/14651858.CD003263.pub4-BIB28|cit28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0781.2006.00250.x","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-Yuan","year":"2006","journal-title":"Photodermatology, Photoimmunology and Photomedicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB29|cit29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo","volume":"142","author":"Mehrabi","year":"2006","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB30|cit30","series-title":"Journal of the American Academy of Dermatology","first-page":"P167","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UVB plus tacrolimus 0.1% ointment vs narrowband UVB pls placebo ointment in the treatment of generalized vitiligo; 2005 63rd Annual Meeting of the American Academy of Dermatology","author":"Mehrabi","year":"2005"},{"key":"10.1002\/14651858.CD003263.pub4-BIB31|cit31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: A randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB32|cit32","first-page":"260","article-title":"Autologous skin minigraft and ingestion of 8-methoxypsoralen in patients with stable vitiligo vulgaris","volume":"46","author":"Navarro","year":"2002","journal-title":"Dermatologia Rev Mex"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB33|cit33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-4362.2002.01391.x","article-title":"Comparison of two surgical approaches for treating vitiligo: A preliminary study","volume":"41","author":"Ozdemir","year":"2002","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB34|cit34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000083091","article-title":"Living with vitiligo: A controlled investigation into the effects of group cognitive-behavioural and humanistic therapies","volume":"5","author":"Papadopoulos","year":"2004","journal-title":"Dermatology and Psychosomatics"},{"key":"10.1002\/14651858.CD003263.pub4-BIB35|cit35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000017991","article-title":"Combination of PUVAsol and topical calcipotriol in vitiligo","volume":"197","author":"Parsad","year":"1998","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB36|cit36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: A synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB38|cit38","first-page":"165","article-title":"Safety and therapeutic effectiveness of 8 MOP, TMP and psoralen in vitiligo","volume":"66","author":"Pathak","year":"1984","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD003263.pub4-BIB39|cit39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/09546639509097164","article-title":"Ineffectiveness of topical khellin in photochemotherapy of vitiligo","volume":"6","author":"Procaccini","year":"1995","journal-title":"The Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD003263.pub4-BIB40|cit40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD003263.pub4-BIB41|cit41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labelled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB42|cit42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2005.12.006","article-title":"Systematic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study","volume":"41","author":"Reyes","year":"2006","journal-title":"Journal of Dermatological Science"},{"key":"10.1002\/14651858.CD003263.pub4-BIB43|cit43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2133.2008.08906.x","article-title":"Randomised, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo","volume":"160","author":"Rodriguez-Martin","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB44|cit44","first-page":"21","article-title":"Evaluation of an antioxidant and mitochondrial stimulating cream formula in the skin of patients with stable vulgar vitiligo","volume":"48","author":"Rojas-Urdaneta","year":"2007","journal-title":"Investigacion Clinica"},{"issue":"9-10","key":"10.1002\/14651858.CD003263.pub4-BIB45|cit45","first-page":"513","article-title":"4-5-8 trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children","volume":"66","author":"Ruiz-Maldonado","year":"1975","journal-title":"Actas Dermosifiliograficas"},{"key":"10.1002\/14651858.CD003263.pub4-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-3083.2008.02839.x","article-title":"A double-blind randomized trial of 0.05% betamethasone vs. topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclement","year":"2008","journal-title":"European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB47|cit47","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB48|cit48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase","volume":"41","author":"Schallreuter","year":"2002","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB49|cit49","first-page":"1013","article-title":"Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra-violet-A","volume":"26","author":"Sharquie","year":"2005","journal-title":"Saudi Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB50|cit50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11655-008-0303-1","article-title":"Clinical observation on the effect of Zengse pill in treating patients with vitiligo of Qi-stagnancy and blood-stasis syndrome type","volume":"14","author":"Shi","year":"2008","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB51|cit51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000247142","article-title":"L-phenylalanine and UVA irradiation in the treatment of vitiligo","volume":"188","author":"Siddiqui","year":"1994","journal-title":"Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB52|cit52","first-page":"237","article-title":"Comparative study between melagenina and placebo in the treatment of vitiligo","volume":"72","author":"Souto","year":"1997","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1002\/14651858.CD003263.pub4-BIB53|cit53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-4632.2004.02403.x","article-title":"Efficacy of autologous transplantation of non-cultured epidermal suspension in two different dilutions in the treatment of vitiligo","volume":"45","author":"Tegta","year":"2006","journal-title":"Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB54|cit54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/000155502320624113","article-title":"Treatment of vitiligo vulgaris with narrowband UVB (311nm) for one year and the effect of addition of folic acid and vitamin B12","volume":"82","author":"Tjioe","year":"2002","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD003263.pub4-BIB55|cit55","first-page":"1203","article-title":"Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo","volume":"140","author":"Geel","year":"2004","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB56|cit56","first-page":"308","article-title":"Vitiligo and intralesional steroids","volume":"69","author":"Vasistha","year":"1979","journal-title":"The Indian Journal of Medical Research"},{"issue":"Sept","key":"10.1002\/14651858.CD003263.pub4-BIB57|cit57","first-page":"1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UVA vs either fluticasone propionate or UVA alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB58|cit58","series-title":"Archives of Dermatology","first-page":"578","article-title":"Randomized double-blind trial of treatment of vitiligo. Efficacy of psoralen- UVA therapy vs narrowband LTV-B therapy; 2007 15th Annual Meeting of the Photomedicine Society","author":"Yones","year":"2007"},{"key":"10.1002\/14651858.CD003263.pub4-BIB59|cit59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomized double blind trial of treatment of vitiligo","volume":"143","author":"Yones","year":"2007","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003263.pub4-BIB60|cit60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00042728-200802000-00005","article-title":"Punch grafting versus suction blister epidermal grafting in the treatment of stable lip vitiligo","volume":"34","author":"Babu","year":"2008","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003263.pub4-BIB61|cit61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-0781.2001.170403.x","article-title":"PUVA and PUVB in vitiligo - Are they equally effective?","volume":"17","author":"Mofty","year":"2001","journal-title":"Photodermatology Photoimmunology & Medicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB62|cit62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0781.2006.00189.x","article-title":"Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: Two right-left comparison studies","volume":"22","author":"Mofty","year":"2006","journal-title":"Photodermatology Photoimmunology & Photomedicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB63|cit63","first-page":"63","article-title":"A clinical and immunological study of the effect of the different modalities of treatment on vitiligo patients","volume":"8","author":"Zawahry","year":"1997","journal-title":"Journal of the Pan-Arab League of Dermatologists"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB64|cit64","first-page":"69","article-title":"Comparative evaluation of different regimens in the treatment of vitiligo","volume":"39","author":"Ghosh","year":"1994","journal-title":"Indian Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB65|cit65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/0378-6323.41405","article-title":"Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo","volume":"74","author":"Godse","year":"2008","journal-title":"Indian Journal of Dermatology Venereology and Leprology"},{"issue":"3-4","key":"10.1002\/14651858.CD003263.pub4-BIB66|cit66","first-page":"45","article-title":"Double blind comparative study between melagenina and placebo in the treatment of vitiligo","volume":"25","author":"Rondon Lugo","year":"1987","journal-title":"Dermatologia Venezolana"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB67|cit67","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2009.09252.x","article-title":"A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","volume":"161","author":"Bakis-Petsoglou","year":"2009","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB68|cit68","unstructured":"Dearman B Greenwood J The use of melanocyte\/keratinocyte-suspension for the re-pigmentation of amelanotic patches in vitiligo Australian New ZealandClinical Trials Registry 2005"},{"issue":"7","key":"10.1002\/14651858.CD003263.pub4-BIB69|cit69","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB70|cit70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","article-title":"The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of non-segmental childhood vitiligo: A randomized placebo-controlled study","volume":"26","author":"Farajzadeh","year":"2009","journal-title":"Pediatric Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB71|cit71","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan","year":"2009","journal-title":"Pediatric Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB72|cit72","unstructured":"Lanigan SW A prospective within-patient randomised controlled trial of the treatment of vitiligo with the 308-nm laser: A pilot study meta Register of Clinical Trials 2004"},{"key":"10.1002\/14651858.CD003263.pub4-BIB73|cit73","unstructured":"Linthorst Homan MW NB-UVB phototherapy versus Excimer laser after mini-grafting in vitiligo patients Controlled-Trials.com 2006"},{"key":"10.1002\/14651858.CD003263.pub4-BIB74|cit74","series-title":"Journal of Investigative Dermatology","first-page":"2685","article-title":"Randomised controlled trial of minigrafting versus recell in stable vitiligo","author":"Martin","year":"2007"},{"key":"10.1002\/14651858.CD003263.pub4-BIB75|cit75","unstructured":"Nordal EL Treatment of vitiligo with narrowband UVB (TL01) combined with tacrolimus (0.1%) versus placebo ointment, a randomized right\/left double blind comparative study ClinicalTrials.gov 2005"},{"issue":"8","key":"10.1002\/14651858.CD003263.pub4-BIB76|cit76","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1468-3083.2009.03138.x","article-title":"Response of vitiligo to once-vs twice daily topical tacrolimus: A controlled prospective, randomized, observer-blinded trial","volume":"23","author":"Radakovic","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB77|cit77","series-title":"Journal of the American Academy of Dermatology","first-page":"AB170-AB170 Sup","article-title":"A double-blind randomized trial of 1% pimecrolimus versus 0.05% clobetasol propionate for the treatment of vitiligo","author":"Seckin","year":"2007"},{"key":"10.1002\/14651858.CD003263.pub4-BIB78|cit78","first-page":"Epub ahead of p","article-title":"An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo","volume":"Aug 4","author":"Stinco","year":"2009","journal-title":"European Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB79|cit79","series-title":"Journal of the American Academy of Dermatology","first-page":"AB196-AB196 Sup","article-title":"Management of vitiligo with 5% polyphenone (-EGCg) in a hydrophilic cream. A placebo-controlled, double-blind study","author":"Syed","year":"2006"},{"key":"10.1002\/14651858.CD003263.pub4-BIB80|cit80","unstructured":"Alghamdi KM Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo: A Randomized Double - Blind Placebo Controlled Trial ClinicalTrials.gov 2009"},{"key":"10.1002\/14651858.CD003263.pub4-BIB81|cit81","unstructured":"Hofer A Efficacy of Narrow-Band UVB treatment after transplantation of harvested epidermal cells in vitiligo ClinicalTrials.gov 2008"},{"key":"10.1002\/14651858.CD003263.pub4-BIB82|cit82","unstructured":"Pandya A The efficacy of hand-foot narrow-band UVB versus focal 308-nm treatment in inducing repigmentation of vitiligo after minigrafting on the dorsal hands ClinicalTrials.gov 2008"},{"key":"10.1002\/14651858.CD003263.pub4-BIB83|cit83","unstructured":"Picardo M Continuative vs Sequential Phototherapy in Non-Segmental Vitiligo Patients ClinicalTrials.gov 2007"},{"key":"10.1002\/14651858.CD003263.pub4-BIB84|cit84","unstructured":"Sachan S Pujari G Assessment of safety and efficacy of ReliDerm\u00aeM in the treatment of stable vitiligo Clinical Trials Registry - India 2009"},{"issue":"2","key":"10.1002\/14651858.CD003263.pub4-BIB85|cit85","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2133.1994.tb02900.x","article-title":"The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions","volume":"130","author":"Al'Abadie","year":"1994","journal-title":"The British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003263.pub4-BIB86|cit86","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"The Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD003263.pub4-BIB87|cit87","first-page":"51","article-title":"400 cases of vitiligo: A clinico-therapeutic analysis","volume":"17","author":"Behl","year":"1972","journal-title":"Indian Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB88|cit88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0923-1811(92)90017-6","article-title":"Genetic nature of vitiligo","volume":"4","author":"Bhatia","year":"1992","journal-title":"Journal of Dermatological Science"},{"key":"10.1002\/14651858.CD003263.pub4-BIB89|cit89","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/0190-9622(95)90292-9","article-title":"Repigmentation in vitiligo vulgaris by autologous minigrafting: Results in nineteen patients","volume":"33","author":"Boersma","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB90|cit90","first-page":"15","article-title":"Current and emerging therapy for the management of vitiligo","volume":"2","author":"Border\u00e9","year":"2009","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB91|cit91","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn","year":"1988","journal-title":"Clinics in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB92|cit92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0781.2007.00274.x","article-title":"Photoprotective activity of oral polypodium leucotomos extract in 25 patients with idiopathic photodermatoses","volume":"23","author":"Caccialanza","year":"2007","journal-title":"Photodermatology Photoimmunology & Photomedicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB93|cit93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","article-title":"Characterisation of vitiligo antigens","volume":"8","author":"Cui","year":"1995","journal-title":"Pigment Cell Research"},{"issue":"5","key":"10.1002\/14651858.CD003263.pub4-BIB94|cit94","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2133.2008.08464.x","article-title":"In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model","volume":"158","author":"Faas","year":"2008","journal-title":"British Journal Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003263.pub4-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1086\/375451","article-title":"A genomewide screen for generalized vitiligo: Confirmation of AIS 1 on chromosome 1p31 and evidence for additional susceptibility loci","volume":"72","author":"Fain","year":"2003","journal-title":"American Journal of Human Genetics"},{"issue":"6","key":"10.1002\/14651858.CD003263.pub4-BIB96|cit96","first-page":"467","article-title":"Current state of vitiligo therapy--evidence-based analysis of the literature","volume":"5","author":"Forschner","year":"2007","journal-title":"Journal of the German Society of Dermatology"},{"issue":"8 Pt 1","key":"10.1002\/14651858.CD003263.pub4-BIB97|cit97","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00042728-200508000-00007","article-title":"Micropigmentation: Tattooing for medical purposes","volume":"31","author":"Garg","year":"2005","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003263.pub4-BIB98|cit98","first-page":"91","article-title":"Autologous graft by suction blister technique in management of vitiligo","volume":"57","author":"Tawade","year":"1991","journal-title":"Indian Journal Dermatology Venereology Leprology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB99|cit99","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-4362.1992.tb03944.x","article-title":"Non-psoralen treatment of vitiligo. Part ll: Less commonly used and experimental therapies","volume":"31","author":"Goldstein","year":"1992","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB100|cit100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0738-081X(97)00133-8","article-title":"Psoralen photochemotherapy for vitiligo","volume":"15","author":"Grimes","year":"1997","journal-title":"Clinics in Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB101|cit101","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1524-4725.1989.tb03129.x","article-title":"Micropigmentation for the treatment of vitiligo","volume":"15","author":"Halder","year":"1989","journal-title":"The Journal of Dermatologic Surgery and Oncology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB102|cit102","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 5.0.1 [September 2008]","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB103|cit103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Archives of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD003263.pub4-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"New England Journal Medicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB105|cit105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo. A critical incidence analysis","volume":"35","author":"Kent","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003263.pub4-BIB106|cit106","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB107|cit107","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0190-9622(84)80027-4","article-title":"Vitiligo","volume":"11","author":"Klaus","year":"1984","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB108|cit108","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003263.pub4-BIB109|cit109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9343(71)90232-4","article-title":"On the etiology of vitiligo and gray hair","volume":"51","author":"Lerner","year":"1971","journal-title":"American Journal Medicine"},{"key":"10.1002\/14651858.CD003263.pub4-BIB110|cit110","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1978.03280390079031","article-title":"Vitiligo. What is it? Is it important?","volume":"239","author":"Lerner","year":"1978","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003263.pub4-BIB111|cit111","volume-title":"Vitiligo: Current Knowledge and Nutritional Therapy","author":"Montes","year":"2006"},{"key":"10.1002\/14651858.CD003263.pub4-BIB112|cit112","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/9780470760116.ch21","article-title":"PUVA therapy","volume-title":"Vitiligo","author":"Morison","year":"2000"},{"key":"10.1002\/14651858.CD003263.pub4-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archderm.134.12.1532","article-title":"The development of guidelines for the treatment of vitiligo: meta-analysis of the literature","volume":"134","author":"Njoo","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"2 pt 1","key":"10.1002\/14651858.CD003263.pub4-BIB114|cit114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 pt 1","key":"10.1002\/14651858.CD003263.pub4-BIB115|cit115","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2000.103813","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and Q-switched ruby laser","volume":"42","author":"Njoo","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003263.pub4-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"British Journal Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB117|cit117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB118|cit118","doi-asserted-by":"crossref","DOI":"10.1002\/9780470760116.ch29","article-title":"Alternative therapies for vitiligo","volume-title":"Vitiligo: A monograph on the basic and clinical science","author":"Orecchia","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD003263.pub4-BIB119|cit119","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2230.1998.00384.x","article-title":"Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology","volume":"23","author":"Papadopoulos","year":"1998","journal-title":"Clinical and Experimental Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003263.pub4-BIB120|cit120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"The British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB121|cit121","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Quality of Life Outcomes"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB122|cit122","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","article-title":"Psychological reaction to chronic skin disorders: a study of patients with vitiligo","volume":"1","author":"Porter","year":"1979","journal-title":"General Hospital Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003263.pub4-BIB123|cit123","first-page":"493","article-title":"Response to cosmetic disfigurement: Patients with vitiligo","volume":"39","author":"Porter","year":"1987","journal-title":"Cutis"},{"issue":"1 Pt.1","key":"10.1002\/14651858.CD003263.pub4-BIB124|cit124","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","article-title":"The effect of vitiligo on sexual relationships","volume":"22","author":"Porter","year":"1990","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB125|cit125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-4632.2008.03356.x","article-title":"Dihydroxyacetone: A safe camouflaging option in vitiligo","volume":"47","author":"Rajatanavin","year":"2008","journal-title":"Internal Journal Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003263.pub4-BIB126|cit126","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"Journal Eurpean Academy Dermatology Venereology"},{"key":"10.1002\/14651858.CD003263.pub4-BIB127|cit127","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/9780470760116.ch23","article-title":"Pseudocatalase in the treatment of vitiligo","volume-title":"Vitiligo: A monograph on the basic and clinical science","author":"Schallreuter","year":"2000"},{"issue":"2","key":"10.1002\/14651858.CD003263.pub4-BIB128|cit128","first-page":"139-40; discuss","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?","volume":"17","author":"Schallreuter","year":"2008","journal-title":"Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB129|cit129","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1468-3083.2006.01897.x","article-title":"Stigmatization experience, coping and sense of coherence in vitiligo patients","volume":"21","author":"Schmid-Ott","year":"2007","journal-title":"Journal European Academy Dermatology Venereology"},{"issue":"8","key":"10.1002\/14651858.CD003263.pub4-BIB130|cit130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1365-4362.2000.00006.x","article-title":"Use of high dose methylprednsiolone pulse therapy in patients with progressive and stable vitiligo","volume":"39","author":"Seiter","year":"2000","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB131|cit131","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosomes 7(AIS2) and 8 (AIS3), confirmation of SLEVI on chromosome 17, and their role in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"American Journal of Human Genetics"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB132|cit132","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","article-title":"The genetics of generalized vitiligo and associated autoimmune diseases","volume":"20","author":"Spritz","year":"2007","journal-title":"Pigment Cell Research"},{"issue":"8","key":"10.1002\/14651858.CD003263.pub4-BIB133|cit133","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-5945-8-2","article-title":"A systematic review of natural health product treatment for vitiligo","volume":"22","author":"Szczurko","year":"2008","journal-title":"BMC Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB134|cit134","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Research"},{"issue":"5","key":"10.1002\/14651858.CD003263.pub4-BIB135|cit135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: The pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Research"},{"issue":"4","key":"10.1002\/14651858.CD003263.pub4-BIB136|cit136","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1607-551X(08)70115-3","article-title":"Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions","volume":"24","author":"Wu","year":"2008","journal-title":"Kaohsiung Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003263.pub4-BIB137|cit137","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003263.pub3","article-title":"Interventions for vitiligo","author":"Whitton","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003263.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003263.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T23:24:53Z","timestamp":1711149893000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003263.pub4"}},"subtitle":[],"editor":[{"given":"Maxine E","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":137,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003263.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003263.pub5","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2010,1,20]]}}}